About The Study: In this cohort study of sexual and gender minority (SGM) young adults assigned male at birth, exposure to sexual orientation and gender identity change efforts (SOGICE) was associated with adverse cardiovascular health indicators, including elevated diastolic blood pressure and systolic blood pressure, increased systemic inflammation, and higher odds of self-reported hypertension or high blood pressure. These findings underscore the need for public health and policy interventions to enforce and strengthen bans on SOGICE practices. Recognizing the cardiovascular health consequences of SOGICE contributes to addressing SGM health disparities and emphasizes the importance of affirmative care approaches that prioritize the well-being of SGM individuals.

The European College of Neuropsychopharmacology (ECNP) is pleased to announce Professor Carmen Sandi as the recipient of the 2025 ECNP Neuropsychopharmacology Award (preclinical), in recognition of her achievements in advancing the understanding of the neurobiological mechanisms of stress and anxiety and their impacts on brain and behaviour. The ECNP Neuropsychopharmacology Award is presented annually and recognises distinguished research in applied and translational neuroscience.

Women with rheumatoid arthritis, lupus or systemic sclerosis had a higher cardiovascular disease-related death rate than men, signaling a need for improved CVD risk management, finds a new study in journal Circulation: Cardiovascular Quality and Outcomes.

The UK government must urgently draw up a comprehensive national strategy to tackle microplastic pollution or risk falling further behind international efforts to address one of the most pervasive environmental threats of our time, researchers have warned.

A new policy brief, delivered to MPs today (6th May 2025) by the University of Portsmouth’s Global Plastics Policy Centre, outlines the growing scale of the crisis and calls for a coordinated UK roadmap with clear targets and timelines. Developed in collaboration with leading UK microplastics scientists from 7 UK Universities, the brief highlights regulatory gaps and missed opportunities in government policy, despite mounting evidence of harm to human health, ecosystems and the economy.